Clear Proof Clarifying Cleansing Gel

Manufacturer: Mary Kay Inc. | Port Jervis Laboratories Inc. | Englewood Lab Inc.
Effective date: 2024-12-17
Label type: HUMAN OTC DRUG LABEL
Version: 9
Source: full-release
Hydrated at: 2026-06-01 00:44:20

Label at a glance#

ProductClear Proof Clarifying Cleansing Gel Acne Medication

Active ingredientSALICYLIC ACID

Label structure6 sections

Indications and uses

for the management of acne helps prevent new acne pimples

Dosage and administration

cleanse skin thoroughly before applying medication cover the entire affected area with a thin layer and rinse thoroughly one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid (2% W/W)

Purpose

OTC - PURPOSE SECTION

Acne Medication

Uses

INDICATIONS & USAGE SECTION

for the management of acne
helps prevent new acne pimples

Warnings

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
avoid contact with the eyes

Stop use and ask a doctor if

OTC - STOP USE SECTION

irritation or sensitivity develops or increases

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

cleanse skin thoroughly before applying medication
cover the entire affected area with a thin layer and rinse thoroughly one to three times daily
because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
if bothersome dryness or peeling occurs, reduce application to once a day or every other day

Inactive ingredients

INACTIVE INGREDIENT SECTION

arctium lappa root extract, butylene glycol, citric acid, cocamidopropyl betaine, cystoseira amentacea/caespitosa branchycarpa extract, disodium EDTA, DMDM hydantoin, epilobium angustifolium flower/leaf/stem extract, ethylparaben, glycerin, methylparaben, phenoxyethanol, propylene glycol, propylparaben, sodium C14-16 olefin sulfonate, sodium chloride, triethanolamine, water

Principal Display Panel - 127 g carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

clearproof

clarifying cleansing gel

acne medication

2% salicylic acid

4.5 OZ. NET WT. / 127 g

Mary Kay

image of carton

RxCUI, Display, Full name table
RxCUI	Display	Full name	Type	Form / route
1493165	salicylic acid 20 MG/ML Medicated Liquid Soap [Clear Proof Acne Medication]	salicylic acid 20 MG/ML Medicated Liquid Soap [Clear Proof Acne Medication]	SBD Active

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
1493165	clearproof Clarifying 2 % Medicated Liquid Soap	PSN	9
562600	salicylic acid 2 % Medicated Liquid Soap	PSN	9
1493165	salicylic acid 20 MG/ML Medicated Liquid Soap [Clear Proof Acne Medication]	SBD	9
562600	salicylic acid 20 MG/ML Medicated Liquid Soap	SCD	9
1493165	Clear Proof Acne Medication 2 % Clarifying Cleansing Gel	SY	9
1493165	Clear Proof Acne Medication 20 MG/ML Medicated Liquid Soap	SY	9
562600	salicylic acid 2 % Facial Cleanser Toner	SY	9
562600	salicylic acid 2 % Facial Scrub	SY	9
562600	salicylic acid 2 % Medicated Liquid Soap	SY	9

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51531-1349-1	2020-07-22	C162847	48780-1	ab0e2407-3632-f274-e053-dbdaa90a6471	Clear Proof Clarifying Cleansing Gel Drug Facts
51531-1349-4	2020-07-22	C162847	48780-1	ab0e2407-3632-f274-e053-dbdaa90a6471	Clear Proof Clarifying Cleansing Gel Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
51531-1349-1	Clear Proof Clarifying Cleansing GelAcne Medication	28 g in 1 TUBE	GEL	28	9
51531-1349-4	Clear Proof Clarifying Cleansing GelAcne Medication	1 in 1 CARTON	GEL	1	9
51531-1349-4	Clear Proof Clarifying Cleansing GelAcne Medication	127 g in 1 TUBE	GEL	127	9

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51531-1349	CLEAR PROOF CLARIFYING CLEANSING GEL ACNE MEDICATION (SALICYLIC ACID) GEL [MARY KAY INC.]	9	Current NDC, Legacy NDC, 3 package rows	20241219_e06a0132-cd30-4cec-ba2e-d29a120dc17a.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SALICYLIC ACID	ACTIVE INGREDIENT	O414PZ4LPZ	1
SALICYLIC ACID	ACTIVE MOIETY	O414PZ4LPZ	1
ARCTIUM LAPPA ROOT	INACTIVE INGREDIENT	597E9BI3Z3	1
BUTYLENE GLYCOL	INACTIVE INGREDIENT	3XUS85K0RA	1
CITRIC ACID MONOHYDRATE	INACTIVE INGREDIENT	2968PHW8QP	1
COCAMIDOPROPYL BETAINE	INACTIVE INGREDIENT	5OCF3O11KX	1
DMDM HYDANTOIN	INACTIVE INGREDIENT	BYR0546TOW	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	1
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP	INACTIVE INGREDIENT	08H094218D	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	1
SODIUM C14 OLEFIN SULFONATE	INACTIVE INGREDIENT	N816E2SOKI	1
SODIUM CHLORIDE	INACTIVE INGREDIENT	451W47IQ8X	1
TROLAMINE	INACTIVE INGREDIENT	9O3K93S3TK	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

Clear Proof Clarifying Cleansing Gel Acne Medication
Salicylic Acid
SODIUM C14-16 OLEFIN SULFONATE
WATER
COCAMIDOPROPYL BETAINE
SODIUM CHLORIDE
TROLAMINE
EDETATE DISODIUM
PHENOXYETHANOL
BUTYLENE GLYCOL
CITRIC ACID MONOHYDRATE
PROPYLENE GLYCOL
METHYLPARABEN
ETHYLPARABEN
DMDM HYDANTOIN
ARCTIUM LAPPA ROOT
PROPYLPARABEN
GLYCERIN
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51531-1349	51531-1349-4, 51531-1349-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SODIUM C14-16 OLEFIN SULFONATE	O9W3D3YF5U	IACT
WATER	059QF0KO0R	IACT
COCAMIDOPROPYL BETAINE	5OCF3O11KX	IACT
SODIUM CHLORIDE	451W47IQ8X	IACT
TROLAMINE	9O3K93S3TK	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
BUTYLENE GLYCOL	3XUS85K0RA	IACT
CITRIC ACID MONOHYDRATE	2968PHW8QP	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
METHYLPARABEN	A2I8C7HI9T	IACT
ETHYLPARABEN	14255EXE39	IACT
DMDM HYDANTOIN	BYR0546TOW	IACT
ARCTIUM LAPPA ROOT	597E9BI3Z3	IACT
PROPYLPARABEN	Z8IX2SC1OH	IACT
GLYCERIN	PDC6A3C0OX	IACT
EPILOBIUM ANGUSTIFOLIUM FLOWERING TOP	08H094218D	IACT
SALICYLIC ACID	O414PZ4LPZ	ACTIB

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 45 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	GEL / TOPICAL		4 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
DMDM HYDANTOIN	DMDM HYDANTOIN	BYR0546TOW	LOTION / TOPICAL		3 mg	Exact identifier — unii+route 3 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TOPICAL		4522 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TOPICAL		4522 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	GEL / TOPICAL		4 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / TOPICAL	0.18 %w/w		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	GRANULE, FOR SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
TROLAMINE	TROLAMINE	9O3K93S3TK	GEL / TOPICAL		6 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	GEL / TOPICAL		4522 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	GEL / TOPICAL		1 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii+route 3 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	GEL / TOPICAL		1 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / TOPICAL	0.18 %w/w		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
METHYLPARABEN	METHYLPARABEN	A2I8C7HI9T	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PROPYLPARABEN	PROPYLPARABEN	Z8IX2SC1OH	GEL / TOPICAL		4 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
DMDM HYDANTOIN	DMDM HYDANTOIN	BYR0546TOW	LOTION / TOPICAL		3 mg	Exact identifier — unii+route 3 equally ranked IID candidates
SODIUM CHLORIDE	SODIUM CHLORIDE	451W47IQ8X	GEL / TOPICAL	0.18 %w/w		Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	GEL / TOPICAL		14 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii+route 3 equally ranked IID candidates
BUTYLENE GLYCOL	BUTYLENE GLYCOL	3XUS85K0RA	SYSTEM / TOPICAL		1400 mg	Exact identifier — unii+route 3 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	POWDER, FOR SOLUTION / ORAL		13 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
DMDM HYDANTOIN	DMDM HYDANTOIN	BYR0546TOW	LOTION / TOPICAL		3 mg	Exact identifier — unii+route 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
CITRIC ACID MONOHYDRATE	CITRIC ACID MONOHYDRATE	2968PHW8QP	GEL / TOPICAL		1 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
GLYCERIN	GLYCERIN	PDC6A3C0OX	GEL / TOPICAL		500 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SUSPENSION / ORAL		8 mg	Exact identifier — unii candidate 12 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	GEL / TOPICAL		24 mg	Exact identifier — unii+route+dosage form 3 equally ranked IID candidates
ETHYLPARABEN	ETHYLPARABEN	14255EXE39	SOLUTION / ORAL		14 mg	Exact identifier — unii candidate 12 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clear Proof Clarifying Cleansing Gel Acne Medication	SALICYLIC ACID	Mary Kay Inc.	e06a0132-cd30-4cec-ba2e-d29a120dc17a	2024-12-17	Warnings	Exact identifier ndc (package): 51531-1349-1 ndc (package): 51531-1349-4 ndc (product): 51531-1349 ndc11 (package): 51531134901 ndc11 (package): 51531134904 spl id: 2979ed00-f2d2-9a9e-e063-6394a90a9c0b spl set id: e06a0132-cd30-4cec-ba2e-d29a120dc17a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.